Drug rash: Difference between revisions

Line 17: Line 17:
=== Table of Severe Drug Reactions ===
=== Table of Severe Drug Reactions ===
[[File:Characteristics-of-4-main-ddx-DRESS.jpg|900px]]
[[File:Characteristics-of-4-main-ddx-DRESS.jpg|900px]]
{| {{table}}
| align="center" style="background:#f0f0f0;"|'''Charateristic'''
| align="center" style="background:#f0f0f0;"|'''DRESS'''
| align="center" style="background:#f0f0f0;"|'''SJS/TEN'''
| align="center" style="background:#f0f0f0;"|'''AGEP'''
| align="center" style="background:#f0f0f0;"|'''Erythroderma'''
|-
| Onset of eruption||2-6 weeks||1-3 weeks||48 hours||1-3 weeks
|-
| Duration of eruption (weeks)||Several||1-3||<1||Several
|-
| Fever||+++||+++||+++||+++
|-
| Mucocutaneous features||Facial edema, morbilliform eruption, pustules, exfoliative dermattiis, tense bullae, possible target lesions||Bullae, atypical target lesions, mucocutaneous erosions||Facial edema, pustules, tense bullae, possible target lesions, possibl emucosal involvement||Erythematous plaques and edema affecting >90% of total skin surface with or without diffuse exfoliation
|-
| Histological pattern of skin||Perivascular lymphocytcic infiltrate||Epidermal necrosis||Subcorneal pustules||Nonspecific, unless reflecting Sezary syndrome or other lymphoma
|-
| Lymph node enlargement||+++||-||+||+
|-
| Lymph node histology||Lymphoid hyperplasia||-||-||No, unless reflecting Sezary syndrome or other malignancy
|-
| Hepatitis||+++||++||++||-
|-
| Other organ involvement||Interstitial nephritis, pneumonitis, myocarditis, and thydoiditis||Tubular nephritis and tracheobronical necrosis||Possible||Possible
|-
| Neutrophils||Elevated||Decreased||Very elevated||Elevated
|-
| Eosinophils||Very elevated||No change||Elevated||Elevated
|-
| Atypical lymphocytes||+||-||-||+
|-
| Mortality (%)||10||5-35||5||5-15
|}


==Evaluation==
==Evaluation==

Revision as of 18:54, 17 December 2019

Background

ABCs of Drug Rashes

Clinical Features

Morbilliform drug eruption on back
  • Sudden, usually morbilliform, often starts on face & trunk & spreads
  • More polymorphous than viral exanthem

Differential Diagnosis

Erythematous rash

Table of Severe Drug Reactions

Characteristics-of-4-main-ddx-DRESS.jpg

Charateristic DRESS SJS/TEN AGEP Erythroderma
Onset of eruption 2-6 weeks 1-3 weeks 48 hours 1-3 weeks
Duration of eruption (weeks) Several 1-3 <1 Several
Fever +++ +++ +++ +++
Mucocutaneous features Facial edema, morbilliform eruption, pustules, exfoliative dermattiis, tense bullae, possible target lesions Bullae, atypical target lesions, mucocutaneous erosions Facial edema, pustules, tense bullae, possible target lesions, possibl emucosal involvement Erythematous plaques and edema affecting >90% of total skin surface with or without diffuse exfoliation
Histological pattern of skin Perivascular lymphocytcic infiltrate Epidermal necrosis Subcorneal pustules Nonspecific, unless reflecting Sezary syndrome or other lymphoma
Lymph node enlargement +++ - + +
Lymph node histology Lymphoid hyperplasia - - No, unless reflecting Sezary syndrome or other malignancy
Hepatitis +++ ++ ++ -
Other organ involvement Interstitial nephritis, pneumonitis, myocarditis, and thydoiditis Tubular nephritis and tracheobronical necrosis Possible Possible
Neutrophils Elevated Decreased Very elevated Elevated
Eosinophils Very elevated No change Elevated Elevated
Atypical lymphocytes + - - +
Mortality (%) 10 5-35 5 5-15

Evaluation

  • Typically a clinical diagnosis

Management

  • Discontinue offending agent
  • Supportive
  • Topical steroids may help relieve pruritus

Disposition

  • If no signs of anaphylaxis or significant sloughing, consider outpatient management

See Also

External Links

References